Who are E. coli Asparaginase, PEG-L-asparaginase's main competitors?

No direct comparators detected in our index.

How often does this brief refresh?

Every 30 minutes from primary sources (FDA, EMA, MHRA, PMDA, ClinicalTrials.gov, USPTO). Subscribe to the RSS feed below for push alerts.

How do I get this as a recurring report?

Subscribe to /feed/ci/e-coli-asparaginase-peg-l-asparaginase.xml in any RSS reader (Feedly, Inoreader, NewsBlur). Every regulatory action, trial readout, or patent event lands in your feed automatically.

Last reviewed 2026-05-18 · How we verify

E. coli Asparaginase, PEG-L-asparaginase — Competitive Intelligence Brief

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

E. coli Asparaginase, PEG-L-asparaginase (E. coli Asparaginase, PEG-L-asparaginase) competitive landscape: 0 comparators, recent regulatory actions, upcoming PDUFA, patent timeline. Class: Asparaginase enzyme. Area: Oncology.

phase 3 Asparaginase enzyme Asparagine (amino acid substrate) Oncology Small molecule Live · refreshed every 30 min

Target snapshot

E. coli Asparaginase, PEG-L-asparaginase (E. coli Asparaginase, PEG-L-asparaginase) — St. Jude Children's Research Hospital. PEG-L-asparaginase depletes the amino acid asparagine in leukemic cells, which cannot synthesize their own asparagine and thus undergo apoptosis.

Comparator set

Auto-detected by same drug class / molecular target / therapeutic area, ranked by phase + recency. Override with ?vs=slug1,slug2,….

Drug	Generic	Sponsor	Phase	Class	Target	Approval / PDUFA
E. coli Asparaginase, PEG-L-asparaginase TARGET	E. coli Asparaginase, PEG-L-asparaginase	St. Jude Children's Research Hospital	phase 3	Asparaginase enzyme	Asparagine (amino acid substrate)

Recent regulatory actions (last 90 days)

No regulatory actions in the last 90 days for this set.

Upcoming PDUFA dates (next 180 days)

No PDUFA dates in the next 180 days for this set.

Patent timeline (forward window)

No upcoming patent expiries for this set.

Sponsor landscape (Asparaginase enzyme class)

St. Jude Children's Research Hospital · 1 drug in this class

Subscribe to ongoing alerts

Push every new event for this competitive set into your RSS reader, IFTTT/Zapier workflow, or email digest:

Cite this brief

Drug Landscape (2026). E. coli Asparaginase, PEG-L-asparaginase — Competitive Intelligence Brief. https://druglandscape.com/ci/e-coli-asparaginase-peg-l-asparaginase. Accessed 2026-05-18.

Build your own brief

Pick any drug + add comparators:

https://druglandscape.com/ci/{slug} — auto-detected competitors
https://druglandscape.com/ci/{slug}?vs=drug1,drug2,drug3 — explicit comparators
Brand names auto-resolve: /ci/keytruda → 301 → /ci/pembrolizumab